VP of SciClone Pharmaceuticals was just granted 50,000 options

Raymond Anthony Low, VP of SciClone Pharmaceuticals, just received 50,000 options from the company. The strike price of the options received was $4.75, and these expire on October 15, 2023. Low now owns at least 50,000 options on the company.

Some additional info was provided as follows:

Granted under the Issuer's 2005 Equity Incentive Plan. 25% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. SciClone Pha rmaceuticals next reports earnings on November 04, 2014.

To receive a free e-mail notification whenever SciClone Pharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

The Medicines Company And Sciclone Pharmaceuticals Establish Strategic Partnership For Two Cardiovascular Products In China - Dec. 18, 2014
SciClone Pharmaceuticals director just disposed of 15,591 shares - Dec. 11, 2014

   Auto Refresh